KaloBios Pharmaceutical files for bankruptcy
Published Wed, Dec 30, 2015 · 10:02 AM
[BENGALURU] KaloBios Pharmaceuticals Inc, which fired its controversial chief executive, Martin Shkreli, earlier this month, filed for Chapter 11 bankruptcy on Tuesday in the US bankruptcy court for the District of Delaware.
The drugmaker listed both its assets and liabilities in the range of US$1 million to US$10 million.
The move comes on the heels of KaloBios' appeal of the Nasdaq decision to delist its shares.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs
Starbucks points to weaker consumer as profit falls
Restaurant Brands tops estimates as Burger King overhaul pays off
Walmart to shut all health centers in US over lack of profitability
Coca-Cola raises annual sales forecast on global demand, higher prices